
New glaucoma drugs yield large, lasting reductions in intraocular pressure
New Rochelle, NY, February 21, 2018-Two novel ocular hypotensive agents that have just been approved for use in humans—netarsudil and latanoprostene bunod (LBN)—greatly reduce intraocular pressure, with lasting results ...
Feb 21, 2018
0
19